a public good project by the
Synthesis
Company
of California

© 2026

Lunxian Tang | doi.page

0 works0 citations0 h-index

Lunxian Tang

Tongji University(CN)Shanghai Medical College of Fudan University(CN)Shanghai East Hospital(CN)Nanjing Medical University(CN)

Publications by Year

Research Areas

Sepsis Diagnosis and Treatment, Immune Response and Inflammation, Immune cells in cancer, Epigenetics and DNA Methylation, Respiratory Support and Mechanisms

Most-Cited Works

→ Fabrication and superconductivity ofNaxTaS2crystals(2005)119 cited
→ Characteristics of circular RNA expression of pulmonary macrophages in mice with sepsis‐induced acute lung injury(2019)86 cited
→ M2A and M2C Macrophage Subsets Ameliorate Inflammation and Fibroproliferation in Acute Lung Injury Through Interleukin 10 Pathway(2016)84 cited
→ Inhibition of EZH2 prevents acute respiratory distress syndrome (ARDS)-associated pulmonary fibrosis by regulating the macrophage polarization phenotype(2021)72 cited
→ Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy(2019)51 cited
→ Active players in resolution of shock/sepsis induced indirect lung injury: immunomodulatory effects of Tregs and PD-1(2014)44 cited

→ The protective role of NR4A3 in acute myocardial infarction by suppressing inflammatory responses via JAK2-STAT3/NF-κB pathway(2019)43 cited

→ Programmed Cell Death Receptor Ligand 1 Modulates the Regulatory T Cells’ Capacity to Repress Shock/Sepsis–Induced Indirect Acute Lung Injury by Recruiting Phosphatase Src Homology Region 2 Domain-Containing Phosphatase 1(2014)42 cited

→ TAT-SNAP-23 treatment inhibits the priming of neutrophil functions contributing to shock and/or sepsis-induced extra-pulmonary acute lung injury(2014)38 cited

→ Novel pharmacological inhibition of EZH2 attenuates septic shock by altering innate inflammatory responses to sepsis(2019)37 cited